References
- 1Lafeber M, Spiering W, Visseren FLJ, Grobbee DE. Multifactorial prevention of cardiovascular disease in patients with hypertension: the cardiovascular polypill. Current Hypertension Reports. 2016; 18(5): 1–7. DOI: 10.1007/s11906-016-0648-3
- 2World Health Organization. Hypertension Indicators for Improving Quality and Coverage of Services; 2021.
- 3Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, Laurence C, Adebamowo C, Ajayi I, Bajunirwe F, Njelekela M, Chiwanga FS, Reid T, et al. The burden of hypertension in sub-Saharan Africa : A four-country cross sectional study. BMC Public Health. 2015; 15: 1–8. DOI: 10.1186/s12889-015-2546-z
- 4Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: Burden, risk and interventions. Internal and Emergency Medicine. 2016; 11(3): 299–305. DOI: 10.1007/s11739-016-1423-9
- 5Oyeyemi AL, Adeyemi O. Relationship of physical activity to cardiovascular risk factors in an urban population of Nigerian adults. Archives of Public Health. 2013; 71(1): 1–9. DOI: 10.1186/0778-7367-71-6
- 6Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, Stewart S, Sliwa K. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World Journal of Cardiology. 2012; 4(12): 327–340. DOI: 10.4330/wjc.v4.i12.327
- 7Abdullahi A.
National Multi-Sectorial Action Plan for the Non-Communicable Diseases . Federal Ministry of Health, 2019. - 8Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American College of Cardiology. 2017; 70(1): 1–25. DOI: 10.1016/j.jacc.2017.04.052
- 9WHO. ‘Best Buys’ and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases; the updated Appendix 3 of the WHO Global NCD Action Plan 2013-2020. WHO Glob. NCD Action Plan 2013-2020 2017. 2017; 65–70.
https://www.who.int/publications/i/item/WHO-NMH-NVI-17.9 . - 10World Health Organization. Action plan for the prevention and control of noncommunicable diseases in the WHO European Region 2016–2025; 2016.
- 11Boateng D, Wekesah F, Browne JL, Agyemang C, Agyei-Baffour P, De-Graft Aikins A, Smit HA, Grobbee DE, Klipstein-Grobusch K. Knowledge and awareness of and perception towards cardiovascular disease risk in sub-Saharan Africa: A systematic review. PLoS One. 2017; 12(12): 1–21. DOI: 10.1371/journal.pone.0189264
- 12African Development Bank Group. Tracking Africa’s Progress in Figures; 2014.
- 13Okorie PN, Ademowo GO, Saka Y, Davies E, Okoronkwo C. Lymphatic filariasis in Nigeria ; Micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance. PLoS Neglected Tropical Diseases. 2013; 7(9):
e2416 . DOI: 10.1371/journal.pntd.0002416 - 14Adeloye D, Owolabi EO, Ojji DB, Auta A, Dewan MT, Olanrewaju TO, Ogah OS, Omoyele C, Ezeigwe N, Mpazanje RG, et al. Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence. Journal of Clinical Hypertension. 2021; 23(5): 963–977. DOI: 10.1111/jch.14220
- 15Donnell MJO, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Ardila SC, Foscal L. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet. 2010; 376(9735): 112–123. DOI: 10.1016/S0140-6736(10)60834-3
- 16Mcqueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Steyn K, Sanderson JE. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study. Lancet. 2008; 372(9634): 224–233. DOI: 10.1016/S0140-6736(08)61076-4
- 17Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, Mcqueen M, Budaj A, Pais P. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364(9438): 937–952. DOI: 10.1016/S0140-6736(04)17018-9
- 18Hussain MA, Mamun AA, Peters SAE, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. Journal of Epidemiology. 2016; 26(10): 515–521. DOI: 10.2188/jea.JE20150178
- 19Hendriks ME, Wit FWNM, Roos MTL, Brewster LM, Akande TM, de Beer IH, Mfinanga SG, Kahwa AM, Gatongi P. Hypertension in sub-Saharan Africa: Cross-sectional surveys in four rural and urban communities. PLoS One. 2012; 7(3):
e32638 . DOI: 10.1371/journal.pone.0032638 - 20Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nature Reviews: Nephrology. 2020; 16(4): 223–237. DOI: 10.1038/s41581-019-0244-2
- 21Maredza M, Bertram MY, Gómez-Olivé, XF, Tollman SM. Burden of stroke attributable to selected lifestyle risk factors in rural South Africa. BMC Public Health. 2016; 16. DOI: 10.1186/s12889-016-2805-7
- 22Owolabi MO, Sarfo F, Akinyemi R, Gebregziabher M, Akpa O, Akpalu A, Wahab K, Obiako R, Owolabi L, Ovbiagele B. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Glob Health. 2018; 6(4)
e446 . DOI: 10.1016/S2214-109X(18)30002-0 - 23Shukuri A, Tewelde T, Shaweno T. Prevalence of old age hypertension and associated factors among older adults in rural Ethiopia. Integrated Blood Pressure Control. 2019; 12: 23–31. DOI: 10.2147/IBPC.S212821
- 24Sani RN, Connelly PJ, Toft M, Rowa-Dewar N, Delles C, Gasevic D, Karaye KM. Rural-urban difference in the prevalence of hypertension in West Africa: A systematic review and meta-analysis. Journal of Human Hypertension. 2024; 38(4): 352–364. DOI: 10.1038/s41371-022-00688-8
- 25Sarfo FS, Ovbiagele B, Gebregziabher M, Wahab K, Akinyemi R, Akpalu A, Akpa O, Obiako R, Owolabi L, Jenkins C, et al. Stroke among young West Africans: Evidence from the SIREN (stroke investigative research and educational network) large multisite case-control study. Stroke. 2018; 49(5): 1116–1122. DOI: 10.1161/STROKEAHA.118.020783